{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:38:04Z","timestamp":1785274684612,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007437","name":"TrygFonden","doi-asserted-by":"publisher","award":["153678"],"award-info":[{"award-number":["153678"]}],"id":[{"id":"10.13039\/501100007437","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.069","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T08:46:48Z","timestamp":1687510008000},"page":"4879-4887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immediate adverse reactions following COVID-19 vaccination among 16\u201365-year-old Danish citizens"],"prefix":"10.1016","volume":"41","author":[{"given":"K.","family":"Torp Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kusk Povlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hammer Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nygaard Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ulrikka Rask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Meinertz Dantoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marie Thysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rytter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.069_b0005","unstructured":"SSI. Tidslinje for covid-19 2022 [Available from: https:\/\/covid19.ssi.dk\/-\/media\/arkiv\/subsites\/covid19\/presse\/tidslinje-over-covid-19\/covid-19-tidslinje-lang-for-2020-2022-version-2---december-2022.pdf. [Last accessed: 14\/2 2023]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0010","unstructured":"Andersen TM. Effekterne af ikke-farmaceutisk intervention under Covid-19 pandemien - En oversigt Finansministeriet2021 [Available from: https:\/\/fm.dk\/media\/25165\/5-baggrundspapir-effekterne-af-ikke-farmaceutisk-intervention-under-covid-19-pandemien-en-oversigt.pdf. [Last accessed:"},{"key":"10.1016\/j.vaccine.2023.06.069_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physrep.2021.02.001","article-title":"Non-pharmaceutical interventions during the COVID-19 pandemic: A review","volume":"913","author":"Perra","year":"2021","journal-title":"Phys Rep"},{"key":"10.1016\/j.vaccine.2023.06.069_b0020","unstructured":"EMA recommends first COVID-19 vaccine for authorisation in the EU: European Medicines Agency; 2020 [Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-first-covid-19-vaccine-authorisation-eu. [Last accessed: 08-02 2022]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0025","unstructured":"EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU: European Medicines Agency; 2021 [Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-covid-19-vaccine-moderna-authorisation-eu. [Last accessed: 14\/2 2023]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0030","unstructured":"EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU European Medicines Agency2021 [Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu. [Last accessed: 9\/3 2023]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0035","unstructured":"EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU European Medicines Agency2021 [Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-covid-19-vaccine-janssen-authorisation-eu. [Last accessed: 14\/2 2023]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0040","unstructured":"Generelt om vacciner mod COVID-19: L\u00e6gemiddelstyrelsen [Available from: https:\/\/laegemiddelstyrelsen.dk\/da\/nyheder\/temaer\/generelt-om-vacciner-mod-covid-19\/. [Last accessed: 03-03-2022 2022]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0045","doi-asserted-by":"crossref","unstructured":"Potteg\u00e5rd AL, L.C.; Karlstad, \u00d8.; Dahl, Jesper; Andersen, Morten; et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021(373).","DOI":"10.1136\/bmj.n1114"},{"key":"10.1016\/j.vaccine.2023.06.069_b0050","unstructured":"Sundhedsstyrelsen. Pausering af brug af COVID-19 Vaccine AstraZeneca i det danske COVID 19 vaccinationsprogram 2021 [Available from: https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2021\/Corona\/Vaccination\/Notater\/Notat-om-pausering-af-COVID-19-Vaccine-AstraZeneca-i-det-danske-COVID-19-vaccinationsprogram.ashx. [Last accessed: 04.11. 2022]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0055","unstructured":"Sundhedsstyrelsen. Danmark forts\u00e6tter vaccineudrulning uden AstraZeneca-vaccinen 2021 [Available from: https:\/\/www.sst.dk\/da\/Nyheder\/2021\/Danmark-fortsaetter-vaccineudrulning-uden-AstraZeneca-vaccinen. [Last accessed: 14.04.21."},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.069_b0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7657","article-title":"Short-term adverse events after the third dose of the BNT162b2 mRNA COVID-19 vaccine in adults 60 years or older","volume":"5","author":"Auster","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.069_b0065","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1473-3099(22)00146-3","article-title":"COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study","volume":"22","author":"Menni","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.069_b0070","article-title":"Risk factors and incidence rates of self-reported short-term adverse events of COVID-19 vaccine booster dose","volume":"10","author":"Chen","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.06.069_b0075","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.2147\/IDR.S374265","article-title":"Evaluation of prevalence of side-effects associated with booster dose of mRNA-Based COVID-19 vaccine among healthcare workers in eastern province, Saudi Arabia: A descriptive cross-sectional study","volume":"15","author":"Ali","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2023.06.069_b0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.069_b0085","doi-asserted-by":"crossref","DOI":"10.3349\/ymj.2021.62.12.1162","article-title":"Adverse events with the pfizer-BioNTech COVID-19 vaccine among korean healthcare workers","volume":"62","author":"Im","year":"2021","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.069_b0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/00325481.2021.1999708","article-title":"Adverse events report of inactivated COVID-19 vaccine from 4040 healthcare workers","volume":"134","author":"Tosun","year":"2022","journal-title":"Postgrad Med"},{"issue":"6","key":"10.1016\/j.vaccine.2023.06.069_b0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhqr.2021.05.002","article-title":"COVID-19 vaccination among Spanish nephrologists: Acceptance and side effects","volume":"36","author":"Quiroga","year":"2021","journal-title":"J Healthc Qual Res"},{"issue":"9","key":"10.1016\/j.vaccine.2023.06.069_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ph14090873","article-title":"Side effects of mRNA-based COVID-19 vaccine: nationwide phase IV study among healthcare workers in slovakia","volume":"14","author":"Riad","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.069_b0105","article-title":"A survey on the side effects of pfizer\/BioNTech COVID-19 vaccine among vaccinated adults in Saudi Arabia","volume":"13","author":"Mohammed","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.vaccine.2023.06.069_b0110","first-page":"477","article-title":"Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine","volume":"112","author":"Borroni","year":"2021","journal-title":"Med Lav"},{"key":"10.1016\/j.vaccine.2023.06.069_b0115","unstructured":"Hvor mange danskere bliver vaccineret mod covid-19? Statens Serum Institut2020 [Available from: https:\/\/www.ssi.dk\/aktuelt\/nyheder\/2020\/12_hvor-mange-danskere-bliver-vaccineret-mod-covid-19_29122020. [Last accessed: 20\/02 2023]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0120","unstructured":"Sundhedsstyrelsen. Personer med \u00f8get risiko ved COVID-19 - Fagligt grundlag; 2021."},{"key":"10.1016\/j.vaccine.2023.06.069_b0125","unstructured":"Sundhedsstyrelsen. Vaccinationskalender 2021 [Available from: https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2021\/Corona\/Vaccination\/Kalender\/Vaccinationskalender-01072021.ashx?sc_lang=da&hash=2F626F7E6433723A88DE3B36228F8C03. [Last accessed: 03-04 2023]."},{"key":"10.1016\/j.vaccine.2023.06.069_b0130","unstructured":"Sundhedsstyrelsen. Tilbud om 3. stik mod covid-19."},{"key":"10.1016\/j.vaccine.2023.06.069_b0135","unstructured":"Bicovac [Available from: https:\/\/ph.au.dk\/bicovac. [Last accessed: 03-04 2023]."},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.069_b0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1525-1497.2001.016004266.x","article-title":"Somatic symptom reporting in women and men","volume":"16","author":"Barsky","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.069_b0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.vaccine.2023.06.069_b0150","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cmi.2022.03.003","article-title":"Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study","volume":"28","author":"S\u00f8gaard","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.069_b0155","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.069_b0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40264-022-01151-w","article-title":"Description of frequencies of reported adverse events following immunization among four different COVID-19 vaccine brands","volume":"45","author":"Kant","year":"2022","journal-title":"Drug Saf"},{"issue":"78","key":"10.1016\/j.vaccine.2023.06.069_b0165","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abp8328","article-title":"Immune recall improves antibody durability and breadth to SARS-CoV-2 variants","volume":"7","author":"Chen","year":"2022","journal-title":"Sci Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2023.06.069_b0170","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.069_b0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2021.4580","article-title":"Association of vaccine type and prior SARS-CoV-2 infection with symptoms and antibody measurements following vaccination among health care workers","volume":"181","author":"Debes","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.069_b0180","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.jamda.2021.08.024","article-title":"Adverse events following one dose of mRNA COVID-19 vaccination among US nursing home residents with and without a previous SARS-CoV-2 infection","volume":"22","author":"Bardenheier","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.vaccine.2023.06.069_b0185","unstructured":"Coronavirus (COVID-19) Cases Our World in Data2023 [Available from: https:\/\/ourworldindata.org\/covid-cases. [Last accessed: 08-06 2023]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:51Z","timestamp":1759404531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23007582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":37,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23007582"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate adverse reactions following COVID-19 vaccination among 16\u201365-year-old Danish citizens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}